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Abstract
Background: Sequence variability in the hepatitis C virus (HCV) genome has led to the development and
classification of six genotypes and a number of subtypes. The HCV 5′ untranslated region mainly comprises an
internal ribosomal entry site (IRES) responsible for cap-independent synthesis of the viral polyprotein and is
conserved among all HCV genotypes.
Description: Considering the possible high impact of variations in HCV IRES on viral protein production and thus
virus replication, we decided to collect the available data on known nucleotide variants in the HCV IRES and their impact
on IRES function in translation initiation. The HCV IRES variation database (HCVIVdb) is a collection of naturally occurring
and engineered mutation entries for the HCV IRES. Each entry contains contextual information pertaining to the entry
such as the HCV genotypic background and links to the original publication. Where available, quantitative data on the
IRES efficiency in translation have been collated along with details on the reporter system used to generate the data.
Data are displayed both in a tabular and graphical formats and allow direct comparison of results from different
experiments. Together the data provide a central resource for researchers in the IRES and hepatitis C-oriented fields.
Conclusion: The collation of over 1900 mutations enables systematic analysis of the HCV IRES. The database is mainly
dedicated to detailed comparative and functional analysis of all the HCV IRES domains, which can further lead to the
development of site-specific drug designs and provide a guide for future experiments. HCVIVdb is available at http://
www.hcvivdb.org.
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Background
Although the hepatitis C virus (HCV) is an important
pathogen infecting between 150 and 200 million people
worldwide, the existence of the virus was not proven
until 1989 [1, 2]. Hepatitis C virus often develops
chronic infections with a long asymptomatic initial
phase, which can, however, result in liver cirrhosis and
cancer. The standard therapy for treatment of HCV in
patients comprises a combination of pegylated interferon
(peg-IFN) and the nucleoside analogue ribavirin. This is
currently being complemented with several direct-action
antivirals targeting viral proteases, polymerase and/or
helicase. However, efficiency of either treatment is
dependent on the HCV genotype, and resistant viruses
have appeared almost concurrently with introduction of
the new antivirals on the market [3, 4].
HCV is a single stranded positive-sense RNA virus from
the genus Hepacivirus, a member of the Flaviviridae family.
Phylogenetic studies have suggested six genotypes of HCV
with several subtypes within each of them. It is thought that
all of the genotypes share a common ancestor 300–400
years ago [5]. Whereas there are significant variations
within the protein-coding segment of the genome, the 5′
UTR containing the internal ribosome entry site (IRES),
which is responsible for viral genome translation, is rela-
tively strongly conserved among all genotypes.
The HCV IRES spans a region of ~341 nucleotides
and is composed of structurally distinct domains I, II, III
and IV [6, 7]. Both sequence and structural conservation
of HCV IRES are important to maintain its direct and
functional contacts with the translational machinery and
deliver an optimal yield of viral protein synthesis. Recent
cryo-electron microscopy (cryo-EM) and molecular
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modelling experiments further advanced our knowledge
on molecular interactions between the HCV IRES and ri-
bosomes and our understanding of coordinated structural
rearrangements within the HCV IRES and associated com-
plexes, which are crucial for translation initiation [8–11]
The close relationship between HCV IRES structure and
function has also been reviewed recently [12].
The analysis of HCV IRES mutation data and the
effects of mutations on translational efficiency is not a
simple task. The data generated from thousands of ex-
periments are spread across many journal articles, with
no standardized reporting format. Information has often
been presented within figures, severely limiting compu-
tational parsing and subsequent analysis. Prior to the
development of the HCVIVdb, there was no central
repository for the various mutations observed within the
HCV IRES. We have developed a syntax for collating
this information and, to date, have generated a dataset
containing 1564 entries comprising 1967 sequence varia-
tions. The collected data have been characterized in
multiple categories that assist the users in conducting
comparative and functional analyses among various
HCV IRES regions.
Construction and content
All HCV IRES entries were manually gathered from the
majority of published studies that dealt with modifications
in the HCV IRES either occurring naturally in HCV pa-
tients subjected and/or not subjected to antiviral therapy or
with modifications intentionally introduced to the viral gen-
ome by in vitro mutagenesis. The aim of most of these indi-
vidual studies was to evaluate the impact of HCV IRES
variants on the translation of the viral RNA genome and/or
its replication. The entries obtained manually from these
studies were arranged to reflect the availability of published
information including HCV genotype, nucleotide changes,
systems used to monitor translation efficiency, activity in
translation assays, plasmid constructs and reporter genes
used, clinical data and the original publication reference.
Entries were aligned with the respective HCV reference
genome of the particular study (Table 1).
The architecture of the HCVIVdb was designed to be
efficient and user-friendly to maximize utilization of the
data and their application by users. For this purpose, the
manually collected variations of the HCV IRES were fur-
ther classified into different categories for easier access to
information and wide-range analysis. The search engine
provides users with access to all HCV IRES mutation
types ranging from point and multiple substitutions to
insertions and deletions. Each entry has been given a
unique ID and all entries have been divided into the two
main distinct groups of naturally occurring and engineered
variations (Fig. 1). A nomenclature was adopted whereby
e.g. U 80 C denotes a single nucleotide substitution where
uracil is replaced by cytosine at position 80. To describe the
HCV IRES structure, a designation ‘domain’ was used to
represent all the domains and subdomains with proper
numbering (domain II, III, IIIa, IIIb etc.). Entries were
further classified according to the respective variations’
presence in HCV IRES domain I through IV, their geno-
type, the measured activity in a translation assay, etc. All
entries are available with respective publication references
and direct links to the PubMed ID. This permits users to
access the original source where the entry was reported and
retrieve any further required details.
The analytical tools available on the database website
allow for browsing through variation entries grouped
according to individual domains and sub-domains (10
categories) of the HCV IRES, according to their geno-
types and according to the original publication. Entries
containing data regarding translational activity can be
browsed within five categories differing in a range of the
measured translational efficiency relative to the wild type
control in the respective experiments. Users can easily
and quickly reach all available HCV IRES variations fall-
ing into one of the following categories of translational
efficiency: 0–25 %, 26–50 %, 51–76 %, 76–100 % and
over 100 % of the wild type. This option allows for quick
elucidation of regions more or less sensitive to individual
and/or multiple IRES modifications. The database con-
tains an extensive search tool as well, which allows users
to search through the entries according to one or more
of the following parameters simultaneously: HCVIVdb
ID, mutation type (point substitution, any substitution,
insertion and deletion), whether the variation is natural
or engineered, nucleotide position and/or nucleotide
range within the IRES, domains and subdomains, range
of translational efficiency, author, keywords and original
publication (Fig. 1). The entries have been organized so
that searching for a distinct variation allows evaluation
of other entries with identical mutations along with mu-
tations at the same location. The selection of these
Table 1 Assembly of HCV IRES data collected from publications
contains various fields/experimental parameters to study various
aspects of viral translation. Example is from Barria et al. [22]
Data classification Example
Mutation(s) U 80 C
Translational activity 52 ± 5
HCV genotype 1b
Reporter genes RLuc/FLuc
Translational system Rabbit reticulocyte lysate (RRL)
Natural or Engineered Natural
Notes 19 patients, naïve to antiviral treatment
Citation Barria et al. [22]
Other Reference sequence: Genotype 1b (AJ238799.1)
Floden et al. BMC Microbiology  (2016) 16:187 Page 2 of 8
supportive mutations can further highlight the informa-
tion regarding their function, genotype and other experi-
mental parameters (Fig. 2).
The data are stored in a MySQL database made up of
several related tables enabling fast and efficient data
access via the web interface. A standard syntax ensures
efficient and accurate parsing of data and allows search-
ing based on relevant criteria. The user interface was
designed to have a simple and easy-to-navigate structure
with key elements including search and results pages.
The search engine allows for targeted queries relevant to
the user. The results are displayed in a real time as dynam-
ically generated tables and graphs using the Google Charts
Application Programming Interface (API). HCVIVdb is
available at the web address http://www.hcvivdb.org.
Utility and discussion
The underlying objective for the development of
HCVIVdb was to gain an insight into the behavior and
mechanics of the HCV IRES. The natural and engi-
neered variations in the domains (I-IV) of the HCV IRES
can impact the efficiency of its translation; therefore, the
compilation of both kinds of mutations provided by the
database can facilitate targeted drug design. The main
aim, however, is to conduct a detailed comparative ana-
lysis of the variability in different regions of the HCV
IRES in relation to its function. With the availability and
characterization of the data into various categories,
HCVIVdb allows users to analyze the impact of nucleo-
tide changes on HCV IRES-mediated translation by their
respective domains, by genotypes and by the range of
translation efficiency (Fig. 1).
In the context of the comparative analysis of available
data, we also discovered some of the mutants reported
in different studies, with nucleotide variations in the
same position but varying translational efficiencies. Ana-
lysis of variations at nucleotide position 297 can serve as
such an example underlining usefulness of the HCVIVdb
for comparative analyses of the impact of HCV IRES
variations on its function. The translational activity of
mutants with a point substitution at location 297 was
found to vary, displaying a response that ranges from a
significant decrease in activity to a complete restoration
in efficiency, relative to the wild type (Fig. 3).
The proposition of nucleotide U297 forming a Watson-
Crick base pair with a bulged-out A288 [13] was consistent
Fig. 1 An overview of the HCVIVdb a) A display of the basic search that permits users to find and sort data using multiple criteria b) A title
banner: searching, browsing, downloading and submitting data are all readily available. c) Data can be browsed according categories such as
domain, subdomain, genotype and translational efficiency to which they pertain
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Fig. 2 The results of the example query. The query was a double mutation in domain IIb and IIIb of the HCV IRES. a) The panel shows all
information available for the HCVIVdb ID depicted. The website immediately offers also an interactive list of all entries containing either the same
mutation(s) or mutation(s) in the same position of the HCV IRES. b) HCVIVdb generates a graphical display of the translational activities of the
entries containing a mutation(s) identical with the entry retrieved by the search engine
Fig. 3 The translational efficiency of HCV IRESs containing mutations at nucleotide U297. Significant variations in activities of the individual HCV
IRESs were found while comparing samples from different studies. The graph also represents double mutations and their respective HCV IRES
translation efficiencies
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with the crystal structure, which showed a looped-out
U297 base pairing with A288 revealing a double-
pseudoknot [14]. Several studies investigating HCV IRES
performance upon substitution of nucleotide U297 showed
decreased activity of the mutated IRES as assayed in rabbit
reticulocyte lysate (RRL), HeLa and/or Cos-7 cells [13–16].
However, similar point mutations introduced at nucleotide
U297 by the Doudna laboratory exhibited responses of the
HCV IRES that are mostly similar to the wild type [14].
The introduction of compensatory mutations at A288-
U297 interhelical base pair (HCVIVdb ID: QQ8KZ [13],
W0DGM [14], both containing two simultaneous substitu-
tions A 288 G and U 297 C, Fig. 3b) restored translational
efficiency to nearly that of the wild type [13, 14], whereas
mutations with altered purine/pyrimidine pairing of the
interhelical base pair and/or purine at nucleotide 297
showed reduction in activity [14]. Interestingly, de-
creased activity of the HCV IRES carrying U 297 C and/
or U 297 A substitution was more profound when
assayed in living cells [15, 16] than in RRL [13, 14]. In
comparison to the double mutant (HCVIVdb ID:
QQ8KZ) at A288-U297 interhelical base pair, which
showed toe-print stops similar to the wild type at posi-
tions G318 and G319 (stem I of the pseudoknot) in both
48S and 80S, the single mutants A 288 G and U 297 C
did not display stops at these locations. This suggests
that single mutants interfere with tertiary interactions
near the pseudoknot, which may disrupt the functional
outcome of translation [13].
Validity of HCVIVdb
To validate the individually reported mutations in
HCVIVdb, we compared the data with our analysis of
the variation frequency at each nucleotide position in a
set of over 2000 full-length HCV genome sequences
from the NIAID Virus Pathogen Database and Analysis
Resource (ViPR) [17]. All sequences were aligned using
the MUSCLE [18] multiple sequence alignment (MSA)
software and the frequency of occurrence of each nu-
cleotide at each position of the HCV IRES (1–356 nu-
cleotides) was counted. The results were compared
with the variability of HCV IRES as obtained from the
natural entries of the HCVIVdb. Both obtained datasets
are in good agreement. Hyper-variable positions in the
multiple sequence alignment of the full-length ViPR
sequences corresponded to the highest number of the
naturally occurring mutations in HCVIVdb, whereas
conserved positions corresponded to the fewest number
of mutations in HCVIVdb. Among the top three hyper-
variable nucleotide counts in the HCVIVdb and ViPR
were nucleotides 204, 243 and 183. Nucleotide 204 is
located in the upper loop of domain IIIb, whereas
nucleotide 243 occurs in the stem III region of the
HCV IRES (Fig. 4).
The nucleotide found at location 204 is mainly cyto-
sine (C) or adenine (A). The presence of a uracil (U)
base was insignificant, and there was almost no guanine
(G) located at position 204 in both the HCVIVdb and
the multiple sequence alignment. This nucleotide has
been shown to be protected from RNase ONE™ ribo-
nuclease cleavage upon attachment to the eukaryotic
initiation factor 3 (eIF3) [19]. Further, HCV IRES trans-
lation efficiency does not seem to be affected by the
observed nucleotide changes at this position (Table 2)
[20–23]. The majority presence of adenine and cytosine
in various HCV genotypes at this location suggests the
evolutionary preservation of nucleotide 204 with A, C,
and U having little impact on translational activity. The
absence of guanine may suggest structural stability that
may not be favorable for IIIb loop conformation and
results in a loss of translational response. Another possi-
bility might be that guanosine at position 204 might
interfere with eIF3 and/or any trans-acting factor biding.
However, all these hypotheses are pure speculations
because no experimental data are available for G at
position 204.
We also came across nucleotides in various HCV IRES
regions that were entirely conserved and where muta-
tional changes in these nucleotides induced a devastating
translational response. Most of the regions that display
more than 90 % sequence conservation either interact
directly with the translational machinery or are needed
for maintenance of the IRES structural configuration,
which is critical for HCV IRES activity. One such region
is in domain IIId of the HCV IRES (266–268) consisting
of the G triplet (Fig. 4). Functional and structural studies
have shown an interaction of the (266–268) GGG in
domain IIId with the 40S subunit, and any nucleotide
changes decrease viral translational efficiency drastically
(Table 2) [23–25]. The (266–268) GGG sequence in
domain IIId has been shown to contact 18S rRNA
through a (1116–1118) CCC sequence in the apical loop
of expansion segment 7 (ES7) with complementary base
pairing, as analyzed through dimethyl sulphate (DMS)
modification [26] and also demonstrated functionally
[27]. A cryo-EM structure of the HCV-IRES bound to
40S ribosome at 3.9Å has also displayed specific contact
sites of the HCV IRES domain IIId loop forming a
kissing complex within the apical loop of ES7, reinforced
by the interaction with domain IIIe [8, 10]. Recently,
structure probing techniques such as selective 2′-OH
acylation analysed by primer extension (SHAPE) and
footprint analysis together with molecular modelling
were employed to visualize and reveal the contact sites
of domain IIId loop and the 18S rRNA. Interaction of
wild type HCV IRES and the IIId loop mutants with 40S
investigated through structural probing alongside 3D
model led to the conclusion that domain IIId loop
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interacts directly with the ribosomal helix 26 of ES7 and
is crucial in coordinated structural re-arrangements of
HCV IRES/18S rRNA upon formation of a binary com-
plex that facilitates HCV mRNA translation [9]. The
extreme conservation of these nucleotide sequences have
also been observed in the MSA which exhibits almost
100 % preservation of GGG nucleotides in all 2006 HCV
genome entries.
Comparison with other databases
The importance of the hepatitis C virus as a threat to
human health and its enormous variability has led to
the creation of specialized public databases serving
both as a data repositories and tools to compare, align
and analyse viral sequences and other HCV-related
data. These databases are designed to focus on different
areas of the HCV, including the sequence variability,
phylogeny, protein structure and immunology. How-
ever, many of these databases are rather old and have
not been updated for years.
One such database is the European hepatitis C virus
database (euHCVdb) designed to analyze the genetic
variability of the HCV genome through a collection of
computer-annotated HCV sequences based on reference
genomes. The well-characterized reference genome of 26
HCV sequences representing 18 subtypes provides fully au-
tomated standardization of nomenclature for all entries
with further description of the genome and proteins along
Fig. 4 The proposed HCV IRES secondary structure (domain II-IV) [31, 32]
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with the genotype, references, cross-references to other da-
tabases, genomic regions and the source of the sequence.
However, some of the tools are no longer functional, and
the last database update is from January 2011 [28].
Another such database, the Los Alamos Sequence and
Immunology Database, was modeled upon an HIV data-
base that permits for storage of large sequence sets in the
database along with dynamic alignment [29]. The database
has been designed for users to align and evaluate HCV
sequence data that are deposited in GenBank. The infor-
mation may include genotype, subtype, sampling country
and year, isolate names, etc. It may also include additional
annotated fields and data regarding sequence and patient
information. The data are made accessible through tools
allowing searches on some 30 different fields with auto-
matic exclusion of sequences such as from non-human
hosts or those that are epidemiologically related (either
from one patient or from a cluster of linked infections).
Searching for all sequences of a particular genomic region
(e.g., E1 and E2) is available with the possibility of down-
loading the result as an alignment. The other section of
the database addresses molecular immunology and con-
tains lists of the defined HCV epitopes that are searchable
[30]. However, this part of the database has not been
maintained since September 2007.
HCVIVdb, compared to these databases, is more specific
with regards to its aim of displaying IRES variation data
specifically and in a precise manner. It is unique in provid-
ing a centralized repository for HCV IRES mutations along
with the functional consequences of these mutations. It me-
diates transfer and display of information about mutations
in the HCV IRES gathered from well-defined published
sources along with added information and analysis tools.
We hope that HCVIVdb may help in functional analyses of
particular HCV IRES regions or nucleotides.
Some additional databases that address the hepatitis C
virus are summarized in the Additional file 1.
Conclusion
HCVIVdb is a specialized relational database that fo-
cuses on the reported variations of the HCV IRES that
have been found in patients and/or purposely intro-
duced to the viral genome and on the impact of these
variations on HCV IRES activity. The database offers
insight into the functional significance of the HCV
IRES domains, subdomains, regions and even individual
nucleotides. The design of the database permits users
to access, analyze and download relevant information
through the sophisticated but user-friendly graphical
interface. The HCVIVdb is an efficient and helpful tool
for people working in both the HCV and IRES fields
and can aid in the understanding of the IRES function,
development and design of new experiments and in a
targeted drug design.
Availability and requirements
HCVIVdb is freely available at http://hcvivdb.org/. Sci-
entists are encouraged to submit their data concerning
HCV IRES mutations either through the dedicated form
within the HCVIVdb web site or directly to the corre-
sponding author. New entries will be added in batches
by the database curators.
Additional file
Additional file 1: A list of online databases related to the hepatitis C
virus. Sections are categorized based on the content of the database, tools
available and the link to the relevant website and publication. (PDF 232 kb)
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Table 2 An example of translational efficiencies of HCV IRESs
containing variations of some hypervariable and/or conserved
nucleotides as revealed from the HCVIVdb data analysis
Hypervariable nucleotides Translational activity % References
A 204 C ~100 [20]
C 204 U 109 ± 9 [22]
C 204 U ~80 [21]
U 204 A Retains full activity [23]
A 243 G 92 [20]
G 203 A + G 243 A 100 [20]
C 204 A + G 243 A 83 [21]
Conserved nucleotides Translational activity % References
G 266 A 5 [25]
G 266 C 3 [23]
G 267 C >95 reduction in activity [24]
G 267 C 2 [23]
G 268 C >95 reduction in activity [24]
G 268 C 3 [23]
Floden et al. BMC Microbiology  (2016) 16:187 Page 7 of 8
Author details
1Department of Genetics & Microbiology, Faculty of Science, Charles
University in Prague, Viničná 5, 128 44 Prague 2, Czech Republic. 2Centre for
Genomic Regulation (CRG), The Barcelona Institute of Science and
Technology, Dr. Aiguader 88, Barcelona, Spain. 3Universitat Pompeu Fabra
(UPF), Barcelona, Spain.
Received: 10 March 2016 Accepted: 4 August 2016
References
1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation
of a cDNA clone derived from a blood-borne non-A, non-B viral-hepatitis
genome. Science. 1989;244(4902):359–62. doi:10.1126/science.2523562.
2. Gravitz L. A smouldering public-health crisis. Nature. 2011;474(7350):S2–4.
3. Sarrazin C. The importance of resistance to direct antiviral drugs in HCV
infection in clinical practice. J Hepatol. 2016;64(2):486–504. doi:10.1016/j.jhep.
2015.09.011.
4. Chen ZW, Li H, Ren H, Hu P. Global prevalence of pre-existing HCV variants
resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV
genome data. Sci Rep. 2016;6:20310. doi:10.1038/srep20310.
5. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, et al. The
origin of hepatitis C virus genotypes. J Gen Virol. 1997;78:321–8.
6. Brown EA, Zhang HC, Ping LH, Lemon SM. Secondary structure of the 5′
nontranslated regions of hepatitis-C virus and pestivirus genomic RNAs.
Nucleic Acids Res. 1992;20(19):5041–5. doi:10.1093/nar/20.19.5041.
7. Wang C, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA
in cultured cells is mediated by an internal ribosome-binding mechanism. J
Virol. 1993;67(6):3338–44.
8. Quade N, Boehringer D, Leibundgut M, van den Heuvel J, Ban N. Cryo-EM
structure of Hepatitis C virus IRES bound to the human ribosome at 3.9-A
resolution. Nat Commun. 2015;6:7646. doi:10.1038/ncomms8646.
9. Angulo J, Ulryck N, Deforges J, Chamond N, Lopez-Lastra M, Masquida B, et
al. LOOP IIId of the HCV IRES is essential for the structural rearrangement of
the 40S-HCV IRES complex. Nucleic Acids Res. 2016;44(3):1309–25. doi:10.
1093/nar/gkv1325.
10. Yamamoto H, Collier M, Loerke J, Ismer J, Schmidt A, Hilal T, et al. Molecular
architecture of the ribosome-bound Hepatitis C Virus internal ribosomal
entry site RNA. Embo J. 2015;34(24):3042–58. doi:10.15252/embj.201592469.
11. Hashem Y, des Georges A, Dhote V, Langlois R, Liao HY, Grassucci RA et al.
Hepatitis-C-virus-like internal ribosome entry sites displace eIF3 to gain
access to the 40S subunit. Nature. 2013;advance online publication. doi:10.
1038/nature12658. http://www.nature.com/nature/journal/vaop/ncurrent/
abs/nature12658.html#supplementary-information
12. Khawaja A, Vopalensky V, Pospisek M. Understanding the potential of
hepatitis C virus internal ribosome entry site domains to modulate
translation initiation via their structure and function. Wiley Interdiscip Rev
RNA. 2015;6(2):211–24. doi:10.1002/wrna.1268.
13. Easton LE, Locker N, Lukavsky PJ. Conserved functional domains and a
novel tertiary interaction near the pseudoknot drive translational activity of
hepatitis C virus and hepatitis C virus-like internal ribosome entry sites.
Nucleic Acids Res. 2009;37(16):5537–49. doi:10.1093/Nar/Gkp588.
14. Berry KE, Waghray S, Mortimer SA, Bai Y, Doudna JA. Crystal structure of the
HCV IRES central domain reveals strategy for start-codon positioning.
Structure. 2011;19(10):1456–66. doi:10.1016/j.str.2011.08.002.
15. Lukavsky PJ, Otto GA, Lancaster AM, Sarnow P, Puglisi JD. Structures of two
RNA domains essential for hepatitis C virus internal ribosome entry site
function. Nat Struct Biol. 2000;7(12):1105–10.
16. Psaridi L, Georgopoulou U, Varaklioti A, Mavromara P. Mutational analysis of
a conserved tetraloop in the 5′ untranslated region of hepatitis C virus
identifies a novel RNA element essential for the internal ribosome entry site
function. Febs Lett. 1999;453(1–2):49–53.
17. Pickett BE, Sadat EL, Zhang Y, Noronha JM, Squires RB, Hunt V, et al. ViPR: an
open bioinformatics database and analysis resource for virology research.
Nucleic Acids Res. 2012;40(D1):D593–8. doi:10.1093/Nar/Gkr859.
18. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high
throughput. Nucleic Acids Res. 2004;32(5):1792–7. doi:10.1093/Nar/Gkh340.
19. Sizova DV, Kolupaeva VG, Pestova TV, Shatsky IN, Hellen CU. Specific
interaction of eukaryotic translation initiation factor 3 with the 5′
nontranslated regions of hepatitis C virus and classical swine fever virus
RNAs. J Virol. 1998;72(6):4775–82.
20. Motazakker M, Preikschat P, Elliott J, Smith CA, Mills PR, Oien K, et al.
Translation efficiencies of the 5′-untranslated region of genotypes 1a
and 3a in hepatitis C infected patients. J Med Virol. 2007;79(3):259–69.
doi:10.1002/Jmv.20794.
21. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC.
Identification of unique hepatitis C virus quasispecies in the central nervous
system and comparative analysis of internal translational efficiency of brain,
liver, and serum variants. J Virol. 2004;78(10):5170–83. doi:10.1128/Jvi.78.10.
5170-5183.2004.
22. Barria MI, Gonzalez A, Vera-Otarola J, Leon U, Vollrath V, Marsac D, et al.
Analysis of natural variants of the hepatitis C virus internal ribosome entry
site reveals that primary sequence plays a key role in cap-independent
translation. Nucleic Acids Res. 2009;37(3):957–71. doi:10.1093/Nar/Gkn1022.
23. Kieft JS, Zhou KH, Jubin R, Murray MG, Lau JYN, Doudna JA. The hepatitis
C virus internal ribosome entry site adopts an ion-dependent tertiary fold.
J Mol Biol. 1999;292(3):513–29.
24. Jubin R, Vantuno NE, Kieft JS, Murray MG, Doudna JA, Lau JYN, et al.
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId
contains a phylogenetically conserved GGG triplet essential for
translation and IRES folding. J Virol. 2000;74(22):10430–7.
25. Laporte J, Malet I, Andrieu T, Thibault V, Toulme JJ, Wychowski C, et al.
Comparative analysis of translation efficiencies of hepatitis C virus 5′
untranslated regions among intra individual quasi species present in
chronic infection: Opposite behaviors depending on cell type. J Virol.
2000;74(22):10827–33.
26. Malygin AA, Kossinova OA, Shatsky IN, Karpova GG. HCV IRES interacts
with the 18S rRNA to activate the 40S ribosome for subsequent steps of
translation initiation. Nucleic Acids Res. 2013;doi:10.1093/nar/gkt632
27. Matsuda D, Mauro VP. Base pairing between hepatitis C virus RNA and 18S
rRNA is required for IRES-dependent translation initiation in vivo. Proc Natl
Acad Sci U S A. 2014;111(43):15385–9. doi:10.1073/pnas.1413472111.
28. Combet C, Garnier N, Charavay L, Grando D, Crisan D, Lopez J, et al.
euHCVdb: the European hepatitis C virus database. Nucleic Acids Res. 2007;
35:D363–6. doi:10.1093/Nar/Gkl970.
29. Gaschen B, Kuiken C, Korber B, Foley B. Retrieval and on-the-fly alignment
of sequence fragments from the HIV database. Bioinformatics. 2001;17(5):
415–8. doi:10.1093/bioinformatics/17.5.415.
30. Kuiken C, Hraber P, Thurmond J, Yusim K. The hepatitis C sequence database
in Los Alamos. Nucleic Acids Res. 2008;36:D512–6. doi:10.1093/Nar/Gkm962.
31. Honda M, Brown EA, Lemon SM. Stability of a stem-loop involving the
initiator AUG controls the efficiency of internal initiation of translation on
hepatitis C virus RNA. RNA. 1996;2(10):955–68.
32. Zhao WD, Wimmer E. Genetic analysis of a poliovirus/hepatitis C virus chimera:
new structure for domain II of the internal ribosomal entry site of hepatitis C
virus. J Virol. 2001;75(8):3719–30. doi:10.1128/JVI.75.8.3719-3730.2001.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Floden et al. BMC Microbiology  (2016) 16:187 Page 8 of 8
